Most disinfection solutions appear effective on paper. Systems are installed, protocols are followed, and environments look clean. Yet in reality, pathogens often remain. Not always visible, not always measured, but still present. This gap between perceived safety and actual pathogen reduction is where risk quietly builds. In many environments, everything can be technically correct and still fail to deliver what truly matters.

At Sterilray, Inc., the focus is not just on implementing disinfection, but on ensuring it performs in real-world conditions. The company develops patented 222nm Far-UV technology designed to deactivate bacteria, viruses, mold, and fungi in seconds across air, surfaces, and liquids, including spaces where human exposure is a factor. The technology is chemical-free, mercury-free, does not produce ozone, and is supported by scientific validation and measurable performance.

With more than 20 years of innovation and over 400 clients globally, Sterilray is built around a simple principle: disinfection is not a one-time task, but an outcome that must be consistently delivered. For organisations operating in environments where failure is not an option, the priority is not just installing a system, but making sure it works as intended, every time.


Sterilray Inc.

Org chart

Teams

Offices

Sterilray Inc.

Org chart

Teams

Offices

Related companies